Orexigen Therapeutics Provides Statement on Termination of the Light Study and Updates on Contrave Collaboration with Takeda Pharmaceuticals
As retailers have fallen under pressure to start the year, we look at retail ETFs for investors who see a buying opportunity.
As the retail sector has rebounded, retail ETFs have become pricey.
An update on the valuations of major indexes.
Consider cost, risk, and portfolio overlap before playing with sector ETFs.
Exchange-traded funds seem to encourage myopia. As the variety of ETFs widens, the individual funds themselves are narrowing. Most of the new ETFs launched in recent months have been sector or industry funds that hone in on ever-thinner slices of the stock market, such as home builders, oil ...
Advisor technology columnist Bill Winterberg's Best Tech for Advisors award winners simplify client deposits, streamline client risk assessment, and push the envelope on custody technology.